BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20947401)

  • 1. Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families.
    Hietala M; Henningson M; Törngren T; Olsson H; Jernström H
    Mol Genet Metab; 2011 Jan; 102(1):82-90. PubMed ID: 20947401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.
    Hietala M; Sandberg T; Borg A; Olsson H; Jernström H
    Hum Reprod; 2007 Jan; 22(1):83-91. PubMed ID: 16920725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.
    Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA
    Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
    Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H
    Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.
    Dagan E; Friedman E; Paperna T; Carmi N; Gershoni-Baruch R
    Eur J Hum Genet; 2002 Nov; 10(11):724-8. PubMed ID: 12404104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Spurdle AB; Antoniou AC; Duffy DL; Pandeya N; Kelemen L; Chen X; Peock S; Cook MR; Smith PL; Purdie DM; Newman B; Dite GS; Apicella C; Southey MC; Giles GG; Hopper JL; Chenevix-Trench G; Easton DF;
    Breast Cancer Res; 2005; 7(2):R176-83. PubMed ID: 15743497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
    Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
    Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer.
    Henningson M; Hietala M; Törngren T; Olsson H; Jernström H
    Fam Cancer; 2011 Jun; 10(2):173-85. PubMed ID: 21113804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
    Cox DG; Blanché H; Pearce CL; Calle EE; Colditz GA; Pike MC; Albanes D; Allen NE; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Canzian F; Chanock S; Clavel-Chapelon F; Feigelson HS; Freedman M; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; Kraft P; LeMarchand L; Lund E; Palli D; Peeters PH; Riboli E; Stram DO; Thun M; Tjonneland A; Trichopoulos D; Yeager M;
    Breast Cancer Res; 2006; 8(5):R54. PubMed ID: 16987421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
    Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
    Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
    Rebbeck TR; Kantoff PW; Krithivas K; Neuhausen S; Blackwood MA; Godwin AK; Daly MB; Narod SA; Garber JE; Lynch HT; Weber BL; Brown M
    Am J Hum Genet; 1999 May; 64(5):1371-7. PubMed ID: 10205268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women.
    Westberg L; Baghaei F; Rosmond R; Hellstrand M; Landén M; Jansson M; Holm G; Björntorp P; Eriksson E
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2562-8. PubMed ID: 11397855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.
    González A; Javier Dorta F; Rodriguez G; Brito B; Rodríguez MA; Cabrera A; Díaz-Chico JC; Reyes R; Aguirre-Jaime A; Nicolás Díaz-Chico B
    Eur J Cancer; 2007 Nov; 43(16):2373-80. PubMed ID: 17728127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
    Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
    Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.
    Terry KL; De Vivo I; Titus-Ernstoff L; Shih MC; Cramer DW
    Cancer Res; 2005 Jul; 65(13):5974-81. PubMed ID: 15994977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite profile in hormonal receptor genes associated with breast cancer.
    Iobagiu C; Lambert C; Normand M; Genin C
    Breast Cancer Res Treat; 2006 Jan; 95(2):153-9. PubMed ID: 16317584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.